Possible 8-Week Cure for Patients with Hepatitis C
Learn more about a new, investigational Hepatitis C drug that has been granted priority review by the FDA. It is meant to help patients without cirrhosis who are new to treatment.
Continue reading »
Learn more about a new, investigational Hepatitis C drug that has been granted priority review by the FDA. It is meant to help patients without cirrhosis who are new to treatment.
Continue reading »
The drugs that are in various stages of development for chronic Hepatitis B and Hepatitis C are transforming the outlook for chronic viral hepatitis.
Continue reading »
Researchers share their unwelcome realization that liver cancer acceleration may be associated with Hepatitis C treatment.
Continue reading »
A new study urges further investigation into L-Carnitine’s place in fighting Hepatitis C.
Continue reading »
Epclusa is the latest antiviral drug to get FDA approval. However, like other Hepatitis C medications, it comes with a price.
Continue reading »
Hepatitis C medications are highly effective, but many patients are unfairly excluded from receiving treatment.
Continue reading »
Learn more about Gilead's new FDA-approved drug that is reshaping treatment for Hepatitis C.
Continue reading »
Did you know that generic antiviral drugs for Hepatitis C patients are just as effective as their brand-name versions (Sovaldi, Daklinza and Rebetol)?
Continue reading »
Find out why BIT225 might potentially be used in combination with new Hepatitis C drugs to help shorten treatment times and improve treatment outcomes.
Continue reading »
Find out the details of the updated drug label.
Continue reading »
You should receive your email with links to the reports shortly. If you do not, please check your spam/junk folder.
If you still haven't received our email after a few minutes, please feel free to contact us.
Close Window